Deals17 Jul 2025, 06:01 pm
Lupin Achieves GMP Certification from TGA Australia for Dabhasa API Facility
AI Summary
Global pharma major Lupin Limited announced that the API manufacturing facility of its wholly owned subsidiary, Lupin Manufacturing Solutions (LMS), in Dabhasa, Gujarat, has received the Good Manufacturing Practice (GMP) certification from the Therapeutic Goods Administration (TGA), Australia’s medicines and medical devices regulator. This reflects the high standard of LMS’s manufacturing practices and expertise, and reinforces Lupin’s commitment to quality, compliance, and operational integrity in the CDMO space.
Key Highlights
- Lupin Limited’s API manufacturing facility in Dabhasa, Gujarat, receives GMP certification from TGA Australia
- The certification reflects the high standard of Lupin Manufacturing Solutions’ manufacturing practices and expertise
- Lupin Manufacturing Solutions offers pharmaceutical CDMO services and is engaged in the manufacturing and supply of APIs
- The certification strengthens Lupin’s commitment to quality, compliance, and operational integrity in the CDMO space
- Lupin Limited is a global pharmaceutical leader with products distributed in over 100 markets, and 15 manufacturing sites and 7 research centers globally